Table 3 Association between caffeine metabolic ratios, risk of at least one hospital admission and length of stays in PsyMetab.
Hospital admission | Lengths of stay | |||||
---|---|---|---|---|---|---|
Predictors | Odds Ratios | 95% CI | p-value | Hazard Ratiosc | 95% CI | p-value |
(Intercept) | 0.06 | 0.02–0.25 | <0.001 | |||
Age (10 years) | 1.56 | 1.42–1.72 | <0.001 | 0.87 | 0.84–0.90 | <0.001 |
Sex (Male) | 0.76 | 0.57–1.01 | 0.059 | 1.11 | 0.99–1.25 | 0.13 |
Psychiatric diagnosisa | ||||||
Mood disorders | 1.54 | 1.06–2.26 | 0.02 | 1.00 | 0.83–1.21 | 0.99 |
Psychotic disorders | 5.88 | 3.86–9.05 | <0.001 | 0.87 | 0.72–1.06 | 0.28 |
Smoking | 0.99 | 0.74–1.34 | 0.97 | 1.14 | 1.01–1.28 | 0.05 |
Caffeine metabolic ratiosb | 1.26 | 1.09–1.46 | 0.002 | 0.89 | 0.84–0.95 | <0.001 |
rs2472297 (TT or CT; ref: CC) | 0.85 | 0.61–1.19 | 0.35 | 0.98 | 0.86–1.12 | 0.79 |
rs4410790 (TT or CT; ref: CC) | 1.34 | 0.99–1.82 | 0.057 | 0.99 | 0.88–1.11 | 0.88 |
rs56113850 (TT or CT; ref: CC) | 1.21 | 0.36–4.01 | 0.75 | 0.82 | 0.44–1.54 | 0.38 |
Clozapine or olanzapine use | 1.59 | 1.05–2.46 | 0.03 | 0.88 | 0.77–1.01 | 0.11 |
Patients | 1019 | 664 | ||||
Observations | 1019 | 1349 |